| Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia |
|
International Journal of Hematology |
Aplastic Anemia |
| Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Rethinking clinical trial endpoints in myelodysplastic syndromes. |
|
Leukemia |
Myelodysplastic Syndromes (MDS) |
| Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant. |
|
Crit Rev Oncol Hematol |
Myelodysplastic Syndromes (MDS) |
| Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic Syndromes |
|
Journal of Clinical Oncology |
Myelodysplastic Syndromes (MDS) |
| Rewriting the rules for care of MDS and AML patients in the time of COVID-19 |
|
Leukemia Research Reports |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
| Rigosertib in Combination With Azacitidine in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia: Results of a Phase 1 Study |
|
Leukemia Research |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
| Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS) |
|
Cancer Causes & Control : CCC |
Myelodysplastic Syndromes (MDS) |
| Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) |
|
Cancers |
Chronic Myelomonocytic Leukaemia (CMML), Myelodysplastic Syndromes (MDS) |
| RNA splicing as a therapeutic target in myelodysplastic syndromes |
|
Seminars in Hematology |
Myelodysplastic Syndromes (MDS) |
